Revolution Medicines
RVMD----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Revolution Medicines(RVMD) predict that the Revenue is 0 (--%), Miss estimate;the EBIT is -445.22 M (-84.92%), Miss estimate;the EPS is -2.29 (-102.7%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B--
0.00B--
-0.00B--%
EBITMiss expectations
-0.45B84.92%
-0.38B57.38%
-0.07B27.54%
EPSMiss expectations
-2.29102.65%
-1.839262.76%
-0.450839.89%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf